We have previously reported a 100% match of the MYD88 mutation status in circulating tumor DNA (ctDNA) extracted from cerebrospinal fluid (CSF) and biopsied tissue in 21 primary and secondary central nervous system lymphoma patients using droplet digital PCR (ddPCR) [8]. The gene discussed is MYD88; the disease is primary central nervous system lymphoma.